Cetera Advisor Networks LLC United Therapeutics Corp Transaction History

Cetera Advisor Networks LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$210.76 - $249.51 $843 - $998	4 Added 0.2%	2,054 $471,000
Q4 2023 Feb 13, 2024	BUY	$214.88 - $256.94 $47,273 - $56,526	220 Added 12.02%	2,050 $450,000
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $106,545 - $124,864	503 Added 37.91%	1,830 $413,000
Q2 2023 Aug 09, 2023	SELL	$205.19 - $232.99 $59,094 - $67,101	-288 Reduced 17.83%	1,327 $292,000
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $5,963 - $7,732	-28 Reduced 1.7%	1,615 $361,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $84,645 - $115,256	411 Added 33.36%	1,643 $456,000
Q3 2022 Nov 10, 2022	BUY	$203.3 - $244.17 $250,465 - $300,817	1,232 New	1,232 $258,000

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.